
R1 RCM RCM
Quarterly report 2022-Q1
added 12-16-2023
Country |
|
IPO year |
- |
Industry |
Health information services |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
266 M |
Market Cap[1] |
$ 3.81 B |
EBITDA (LTM) |
$ 187 M |
P/E (LTM) |
- |
P/S (LTM) |
2.61 |
EPS (LTM) |
-2.13 |
Other stocks of industry "Health information services"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | Nasdaq Global Select Market | ||
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | Nasdaq Global Select Market,SPB | ||
|
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | Nasdaq Global Select Market,SPB | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | Nasdaq Global Select Market,SPB | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | Nasdaq Global Select Market,SPB | ||
|
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | NYSE | ||
|
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | Nasdaq Global Select Market | ||
|
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | Nasdaq Global Select Market | ||
|
iCAD
ICAD
|
- | - | $ 102 M | Nasdaq Capital Market | ||
|
Evolent Health
EVH
|
$ 2.53 | 8.58 % | $ 237 M | NYSE,SPB | ||
|
GoodRx Holdings
GDRX
|
$ 2.15 | -1.83 % | $ 829 M | Nasdaq Global Select Market,SPB | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | Nasdaq Capital Market | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | Nasdaq Global Select Market,SPB | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | Nasdaq Global Select Market | ||
|
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | Nasdaq Global Select Market | ||
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | Nasdaq Global Select Market | ||
|
OptimizeRx Corporation
OPRX
|
$ 5.93 | -3.26 % | $ 102 M | Nasdaq Capital Market | ||
|
Health Catalyst
HCAT
|
$ 1.06 | 6.39 % | $ 74.1 M | Nasdaq Global Select Market,SPB | ||
|
HealthEquity
HQY
|
$ 79.91 | 2.5 % | $ 6.88 B | Nasdaq Global Select Market,SPB | ||
|
Premier
PINC
|
- | - | $ 2.33 B | Nasdaq Global Select Market,SPB | ||
|
Schrödinger
SDGR
|
$ 11.45 | 0.7 % | $ 841 M | Nasdaq Global Select Market,SPB | ||
|
Phreesia
PHR
|
$ 8.56 | 6.2 % | $ 511 M | NYSE | ||
|
Teladoc Health
TDOC
|
$ 5.22 | 2.35 % | $ 920 M | NYSE,SPB | ||
|
10x Genomics
TXG
|
$ 23.58 | 1.33 % | $ 2.76 B | Nasdaq Global Select Market,SPB | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | NYSE | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | Nasdaq Capital Market | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | Nasdaq Global Select Market | ||
|
SCWorx Corp.
WORX
|
$ 1.06 | -30.72 % | $ 7.71 M | Nasdaq Global Select Market | ||
|
American Well Corporation
AMWL
|
$ 5.55 | 6.12 % | $ 89.1 M | NYSE | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | Nasdaq Global Market,SPB | ||
|
HealthStream
HSTM
|
$ 20.37 | 2.46 % | $ 619 M | Nasdaq Global Select Market | ||
|
Omnicell
OMCL
|
$ 35.01 | 1.77 % | $ 1.61 B | Nasdaq Global Select Market,SPB | ||
|
Progyny
PGNY
|
$ 16.98 | 4.17 % | $ 1.46 B | Nasdaq Global Select Market,SPB | ||
|
So-Young International
SY
|
$ 2.69 | 4.26 % | $ 214 M | Nasdaq Global Market | ||
|
Veeva Systems
VEEV
|
$ 158.45 | 4.66 % | $ 25.9 B | NYSE,SPB | ||
|
Zhongchao
ZCMD
|
$ 2.01 | 1.01 % | $ 6.87 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.